In contrast, immunoblot analysis demonstrated downregulation of Beclin-1, Bcl-2, and the LC3II/LC31 ratio in EMC patients, while p62 protein expression was increased (Figure 3A(b),B(b) and Figure 4A(b),B(b)). The gene discussed is BCL2; the disease is extraskeletal myxoid chondrosarcoma.